Category Archives: clinical trials

Five Ways a Good Digital Health Registry Addresses Healthcare System Needs

Posted on October 28, 2016 by

Registries have traditionally been viewed as static repositories of data to be reviewed in a summary fashion after a predetermined time period.  The expanding need for drilled down relevant data has led to the development of creative sophisticated data analytics … Continue reading →

Posted in #digitalhealth, analytics, clinical trials, digital health, digital health technology, EHR, FDA, healthcare economics, Healthcare IT, healthcare reform, healthcare vendors, informatics, mHealth, mobile health, statistics, technology, telehealth | Tagged , , , , , , , , , , | Leave a comment

Five Reasons Why Digital Health Needs Patient Reported Outcomes

Posted on September 1, 2016 by

According to the National Quality Forum, patient reported outcomes or patient reported outcomes measures (PROs) can be defined as “any report of the status of a patient’s health condition that comes directly from the patient, without interpretation of the patient’s … Continue reading →

Posted in #digitalhealth, analytics, clinical trials, digital health, EHR, FDA, healthcare economics, Healthcare IT, healthcare reform, informatics, medical apps, mHealth, mobile health, patient engagement, pharma, remote patient monitoring, technology, telehealth | Tagged , , , , , , , , , , , , , | Leave a comment

Five Ways to Turn Big Data into Relevant Data

Posted on July 6, 2016 by

‘Big Data’ may be defined as data that is so large or complex that it cannot be processed by the usual applications. Current common uses of Big Data in healthcare include the collection of genomic data, insurance claims data, medication prescription … Continue reading →

Posted in #digitalhealth, analytics, clinical trials, digital health, digital health technology, EHR, health insurance, healthcare economics, Healthcare IT, informatics, mHealth, mobile health, patient engagement, remote patient monitoring, Uncategorized | Tagged , , , , , , | 1 Comment

Five Ways Rare Diseases can Benefit from Digital Health Technology

Posted on January 11, 2016 by

Rare diseases present special challenges for patients, families and clinicians alike. Symptoms may be mistaken or assumed to be more common ailments. There is not enough searchable material online for lay people, as most of the data and information might be … Continue reading →

Posted in #digitalhealth, analytics, clinical trials, communications, digital health, digital health technology, EHR, FDA, Healthcare IT, informatics | Tagged , , , , , , , , , , , | 6 Comments

Five Requirements for the Adoption of Genomics as a Digital Health Tool

Posted on October 16, 2015 by

That digital health technologies will be adopted to address the ills of healthcare systems around the world is a foregone conclusion. The challenges of the cost of chronic disease burden, physician and patient dissatisfaction While awareness of digital health is … Continue reading →

Posted in clinical trials, digital health, digital health technology, education, FDA, Healthcare IT, informatics, medical apps, medical devices, mHealth, mobile health, pharma, remote patient monitoring, technology | Tagged , , , , , , , , , , , , , | 4 Comments

Five Reasons why Patient Engagement Means Consumer Engagement

Posted on September 28, 2015 by

In previous posts I have discussed differences between patient empowerment and patient engagement and differences between patient and consumer sensor technologies.  Nevertheless, there are clear threads between consumer and healthcare delivery with regards to adoption of digital technologies. Many of … Continue reading →

Posted in clinical trials, digital health, digital health technology, EHR, health insurance, healthcare economics, healthcare vendors, informatics, medical devices, mHealth, mobile health, patient advocacy, patient engagement, remote patient monitoring | Tagged , , , , , , , , , | 4 Comments

Five Mobile Health Technologies Providers Need to Implement NOW

Posted on July 20, 2015 by

This marks my first post since the sudden death of my chronically ill mother last month. The journey as her caregiver solidified what I believe should be priorities for the adoption of digital health technologies. There are currently many mobile … Continue reading →

Posted in clinical trials, digital health, digital health technology, EHR, FDA, health insurance, healthcare economics, Healthcare IT, healthcare reform, healthcare vendors, informatics, medical apps, mHealth, mobile health, patient engagement, remote patient monitoring, smartphone apps, technology | Tagged , , , , , , , , , , | 2 Comments

Five Ways Professional Medical Societies Can Speed the Adoption of Mobile Digital Health Tools

Posted on June 3, 2015 by

There have been many stated roles of professional medical societies, including standardization of care (best practice), promoting public health, and improving leadership in medicine.  All of these roles can be facilitated with digital health technologies. Most professional societies are recognizing … Continue reading →

Posted in clinical trials, digital health, digital health technology, Healthcare IT, medical apps, medical devices, medical education, mHealth, mobile health, patient advocacy, patient engagement, telehealth | Tagged , , , , , , , | Leave a comment

A New Paradigm for Digital Pharma: The Digital KOL

Posted on April 2, 2015 by

A digital strategy is important for Pharma to remain relevant.  The need to connect with both patients and providers via digital formats and via mobile devices has been dictated by the successful penetration of these types of marketing, educational, and … Continue reading →

Posted in clinical trials, digital health, healthcare economics, Healthcare IT, informatics, medical apps, mHealth, mobile health, smartphone apps, technology, telehealth | Tagged , , , , , , , , | Leave a comment

Five Imperatives for Pharma’s Digital Health Strategy

Posted on September 26, 2014 by

Few would argue that today digital technology represents a critical part of marketing in any business sector.  Though all healthcare stakeholders are usually late to the technology table, market and customer pressure are rapidly accelerating this adoption. It needs to … Continue reading →

Posted in clinical trials, digital health, FDA, healthcare economics, Healthcare IT, medical apps, mHealth, patient advocacy, patient engagement, pharma, technology, telehealth, wireless health | Tagged , , , , , , , , , | 5 Comments